Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial
Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s revision indicator was updated to v3.6.3, signaling a version update; this does not modify the study details themselves.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, signaling a new version in the revision history rather than a modification to the study content.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now shows recruitment as no longer looking for participants, and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. A formatting change updates the Intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag to v3.6.0.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.SummaryDifference0.0%

- Check54 days agoChange DetectedNew May 2026 update dates were added to the Study Record Dates (2026-05-22, 2026-05-27, and 2026-05), while older March 2026 dates (2026-03-10, 2026-03-27, and 2026-03) were removed.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor version update.SummaryDifference0.0%

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.